A Clinical trial to study the effect of the drug KADIKKARA CHENDURAM in patients having Irritable Bowel Syndrome
Phase 2
- Conditions
- Health Condition 1: K90-K95- Other diseases of the digestive system
- Registration Number
- CTRI/2018/12/016633
- Lead Sponsor
- GOVERNMENT SIDDHA MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
IBS-Diarrhoea predominant
Abdominal pain or discomfort often exacerbated by eating
Abdominal distension and increased belching
Dyspepsia, Heartburn, Nausea
Exclusion Criteria
Post infectious IBS (Campylobacter, Salmonella, and Shigella)
Inflammatory Bowel Disease(IBD)
Ulcerative colitis
Crohnâ??s disease
Microscopic colitis
Diverticular Disease
Pregnant women
Patients who are undergone for psychiatric treatment.
Will be excluded clinically or based on available medical reports
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method